Sorting nexins (SNX) represent a diverse family of proteins involved in crucial cellular processes, particularly the regulation of intracellular membrane trafficking and sorting. SNX proteins play a pivotal role in orchestrating the endocytic and recycling pathways within cells, ensuring the precise localization and transport of various membrane-bound cargo proteins. Structurally, SNX proteins are characterized by the presence of one or more phosphoinositide-binding domains, most notably the Phox homology (PX) domain, which enables their association with specific phospholipids in cellular membranes. SNX proteins act as molecular adaptors that interact with other cellular components, such as clathrin, to facilitate the formation of membrane vesicles and the selective sorting of cargo molecules. By recognizing distinct sorting signals in cargo proteins, SNX proteins contribute to the proper routing of cargo between different membrane compartments, including endosomes, lysosomes, the trans-Golgi network, and the plasma membrane. Moreover, SNX proteins can engage in intricate protein-protein interactions with other cellular factors, including GTPases, to modulate membrane dynamics and cellular responses.
Sorting Nexin (SNX) Inhibitors are designed to interfere with the activity or interactions of SNX proteins within the cellular trafficking machinery. These inhibitors serve as valuable tools in research to dissect the roles of SNX proteins and their contributions to membrane dynamics and cargo sorting processes. Some SNX inhibitors may target the phosphoinositide-binding domains of SNX proteins, disrupting their membrane localization and impeding their ability to bind to specific lipids. Others may interfere with protein-protein interactions involving SNX proteins, their association with cargo molecules, adaptors, or other regulatory factors.
VEJA TAMBÉM
Nome do Produto | CAS # | Numero de Catalogo | Quantidade | Preco | Uso e aplicacao | NOTAS |
---|---|---|---|---|---|---|
Hydroxy-Dynasore | 1256493-34-1 | sc-364678 | 10 mg | $250.00 | ||
Este composto também inibe a dinamina e pode, por conseguinte, perturbar a endocitose, afectando potencialmente o ciclo do PSGL1 nos endossomas. | ||||||
Apilimod | 541550-19-0 | sc-480051 sc-480051A | 100 mg 1 g | $420.00 $2600.00 | 5 | |
O apilimod é um inibidor da fosfoinositídeo 3-quinase (PI3K) e foi referido que afecta indiretamente a SNX1 e a SNX2, que estão envolvidas no tráfico endossomal e na remodelação da membrana. | ||||||
Rasagiline | 136236-51-6 | sc-204875 sc-204875A | 25 mg 100 mg | $101.00 $210.00 | ||
A rasagilina é um inibidor da monoamina oxidase-B (MAO-B) e demonstrou afetar a SNX7, um membro da família SNX, alterando potencialmente os processos de ordenação endossómica. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $56.00 $256.00 | 113 | |
O 3-MA inibe a PI3K, conhecida por afetar a autofagia. Dada a relação entre endossomas e autofagossomas, a expressão de SNX33 pode ser influenciada. | ||||||
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $37.00 $77.00 $184.00 $510.00 $1224.00 $5814.00 | 8 | |
A niclosamida inibe a SNX8 ao interferir com o seu papel na sinalização Wnt, levando à perturbação da ordenação da carga endossómica. | ||||||
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $199.00 $599.00 | 24 | |
O GW4869 inibe a esfingomielinase, alterando a composição lipídica nos endossomas e interferindo com os processos de triagem mediados pela SNX8. | ||||||
KPT185 | 1333151-73-7 | sc-487916 | 10 mg | $220.00 | ||
O SAR405 inibe a PI3-quinase, interrompendo as vias de sinalização dos fosfoinositídeos envolvidas na ordenação da carga endossómica mediada pela SNX8. | ||||||
URMC-099 | 1229582-33-5 | sc-492603 | 5 mg | $143.00 | ||
O PF-543 inibe a SphK1, perturbando o metabolismo dos esfingolípidos e afectando indiretamente os processos de triagem endossómica mediados pela SNX8. |